by Jordana Choucair | Jan 6, 2023 | Life Sciences
AstraZeneca PLC and Sanofi SA said the Food and Drug Administration (FDA) indicated it may expedite the review of the companies’ long-acting antibody for the prevention of infection caused by RSV, called nirsevimab, with action possibly coming in the third...
by Jordana Choucair | Jan 6, 2023 | M&A
VillageMD announced it completed its $8.9 billion acquisition of Summit Health-CityMD, creating one of the largest independent physician practices in the country. Walgreens Boots Alliance CEO Roz Brewer said that the acquisition is a key move in Walgreens’...
by Jordana Choucair | Jan 6, 2023 | Payers
The Federal Trade Commission (FTC) released a proposed rule that would ban employee noncompete contract provisions. The proposed rule is one element of the FTC’s broader strategy to limit anticompetitive activity in health care and other industries. Researchers...
by Jordana Choucair | Jan 4, 2023 | Life Sciences
The Food and Drug Administration (FDA) announced it will allow pharmacies to dispense the abortion medication mifepristone to patients. The agency also said it would no longer enforce a rule requiring people to get the first of the two drugs in person at a clinic or...
by Jordana Choucair | Jan 4, 2023 | Life Sciences
Gilead Sciences Inc. and EVOQ Therapeutics Inc. are partnering to develop autoimmune disorder treatments in a deal worth up to $658.5 million. The companies will collaborate on preclinical work for rheumatoid arthritis and lupus treatments, and Gilead will then...
Recent Comments